Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CQSS2 versus NiQuitin patch for smoking cessation cravings
ACTRN12616001529437Phase 2Completed
- Sponsor
- Chrono Therapeutics
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of CQSS2 and nicotine in nicotine dependence (2 arms), sponsored by Chrono Therapeutics. Primary endpoint: Craving profile during quit attempt. Started Dec 2016; status: completed.
02
Drugs
CQSS2nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on ACTRN12616001529437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001529437.